Polypharmacy, i.e. treatment with many drugs may lead to negative health and financial consequences, especially when the patient uses too much drugs, drugs that lead to dangerous interactions, or are just doubled, under different trade names. Professor Kardas discusses this phenomenon in an interview published in the ‘Sluzba Zdrowia’ on the basis of data coming from the latest National Health Fund report, in preparation of which he participated.